期刊文献+

医院感染肺炎克雷伯菌耐药性及氨基糖苷类修饰酶、β-内酰胺酶基因研究 被引量:15

Klebsiella pneumoniae Isolates from Hospital-acquired Infection:Their Drug Resistance and Genotype of Aminoglycoside -modifying Enzyme and β-Lactamases
在线阅读 下载PDF
导出
摘要 目的明确广州地区引起医院感染的肺炎克雷伯菌耐药性及氨基糖苷类修饰酶、β内酰胺酶基因存在状况。方法采用MicroScan微生物鉴定系统NC21试验板微量肉汤法,测定20株医院感染分离的肺炎克雷伯菌对20种抗菌药物的敏感性,采用聚合酶链反应技术分析9种氨基糖苷类修饰酶基因和2种β内酰胺酶基因。结果该20株菌呈现多重耐药,除对亚胺培南敏感率高达95%外,对氨基糖苷类抗菌药物的耐药率在75.0%~90.0%之间,其他药物耐药率为55%~100%;18株(90.0%)检出氨基糖苷类修饰酶基因,ant(3″)Ⅰ、aac(6′)Ⅰ、aac(3)Ⅱ、aac(3)Ⅰ、aac(6′)Ⅱ和aph(3′)Ⅵ基因阳性率分别为80.0%、70.0%、65.0%、35.0%、25.0%和5.0%,aac(3)Ⅲ、aac(3)Ⅳ和ant(2″)Ⅰ基因均阴性;20株菌均检出β内酰胺酶编码基因,其中TEM基因阳性率85.0%,DHA基因阳性率80.0%。结论广州地区临床分离的肺炎克雷伯菌多重耐药严重,氨基糖苷类修饰酶基因和β内酰胺酶编码基因携带率很高,存在DHA型质粒AmpC酶基因。 OBJECTIVE To investigate the antimicrobial resistance and genotyping of aminoglycoside-modifying enzymes (AMEs) and β-lactamases (BLs) in Klebsiella pneumoniae (KPN) isolated from hospital-acquired infection in Guangzhou. METHODS The sensibility of KPN was identified to 20 antibiotics, and the minimum inhibitory concentrations (MIC) were determined by Neg Combo Panel Type 21 (Dade MicroScan). Two BLs genotypes and nine AMEs genotypes in 20 strains of KPN were verified by polymerase chain reaction (PCR) and DNA sequencing technique. RESULTS The 20 strains of KPN were multi-resistant. They only showed high susceptibility to imipenem with 95% susceptible rate, but resistant to aminoglycosides (resistance rates were 75.0-90.0%) and other antibiotics (resistance rates were 55.0-100%). Eighteen strains(90.0%) could be found one or more types of AMEs gene. The rates of ant (3")- Ⅰ , aac(6')- Ⅰ , aac(3)-Ⅱ , aac(3)-Ⅰ , aac(6r)-Ⅱ , aph(3')-Ⅵ, aac(3)-Ⅲ , aac(3)-Ⅳ and ant(2")-Ⅰ genes were 80.0%, 70.0%, 65.0%, 35.0%, 25.0%, 5.0%, 0, 0 and 0, respectively. Twenty strains all could be found BLs gene, including blaTEM (85.0%) and blaDHA (80.0%). CONCLUSIONS The study showed that K. pneurnoniae strains were serious multi-drug resistant and with higher BLs and AMEs gene expression in Guangzhou, and the strains carrying DHA gene could be found generally.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2005年第11期1208-1213,共6页 Chinese Journal of Nosocomiology
基金 耐药基因研究专项基金资助(20040401HD)
关键词 肺炎克雷伯菌 氨基糖苷类修饰酶 Β-内酰胺酶 基因 聚合酶链反应 Klebsiella pneumoniae Aminoglycoside-modifying enzyme β-Lactamases; Gene Polymerase chain reaction
  • 相关文献

参考文献7

二级参考文献14

  • 1陈代杰.抗菌生物与细菌耐药性[M].上海:华东理工大学出版社,2001.90-111.
  • 2Bergogne-Berezin E. Guideline on antimicrobial chemotherapy for prevention and treatment of infections in the ICU. J Chemother, 2001,1: 134-149.
  • 3Goossens H. MYSTIC program: summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis, 2001, 41: 183-189.
  • 4Leblebicioglu H, Gunaydin M, Esen S, et al. Surveillance of antimicrobial resistance in gram-negative isolates from ICU in Turkey:analysis of data from the last 5 years. J Chemother, 2002, 14:140-146.
  • 5Karlowsky JA, Kelly LJ, Thornsberry C , et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000:TRUST and TSN data for the United States. J Autimicrob Agents , 2002,19: 21-31.
  • 6National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. Approved standard M100-S12. National Committee for Clinical Laboratory Standards,Wayne, Pa.2002,1.
  • 7Chanawong A. M' Zali FH, Heritage J, et al. Three cefotaximases,CTX-M-9, CTX-M-13, CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother, 2002, 46:630-637.
  • 8吴伟元,陈民钧,王辉.阴沟肠杆菌去阻遏持续高产AmpC酶和超广谱β-内酰胺酶(ESBLs)的检测[J].中国临床药理学杂志,2001,17(2):104-109. 被引量:201
  • 9俞云松,陈亚岗,周伟琳,马亦林.一种新基因型SHV-28 β-内酰胺酶的发现及其特性的初步研究[J].中华检验医学杂志,2001,24(4):204-206. 被引量:37
  • 10朱戌冬,徐英春,吴伟元,王辉,陈民钧.一种新CTX-M型超广谱β-内酰胺酶及其临床意义[J].中华检验医学杂志,2001,24(4):207-210. 被引量:47

共引文献1042

同被引文献86

引证文献15

二级引证文献166

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部